N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide

C183H200F6N30O16S2 — CID 158114027

IUPACN-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide
SMILESCC(C)(C)CC(=O)Nc1ccc(-c2nc3ccc(NC(=O)CC(C)(C)C)cc3[nH]2)cc1.O=C(Cc1cccs1)Nc1ccc(-c2nc3ccc(NC(=O)Cc4cccs4)cc3[nH]2)cc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4C(=O)C(F)(F)F)cc3[nH]2)cc1)C1CCCC1C(=O)C(F)(F)F.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCCC4)cc3[nH]2)cc1)C1CCCCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCN4)cc3[nH]2)cc1)C1CCCN1
InChIInChI=1S/C29H26F6N4O4.C29H36N4O2.C27H32N4O2.C25H20N4O2S2.C25H28N4O2.C25H32N4O2.C23H26N6O2/c30-28(31,32)23(40)17-3-1-5-19(17)26(42)36-15-9-7-14(8-10-15)25-38-21-12-11-16(13-22(21)39-25)37-27(43)20-6-2-4-18(20)24(41)29(33,34)35;34-28(21-9-5-1-2-6-10-21)30-23-15-13-20(14-16-23)27-32-25-18-17-24(19-26(25)33-27)31-29(35)22-11-7-3-4-8-12-22;32-26(19-7-3-1-4-8-19)28-21-13-11-18(12-14-21)25-30-23-16-15-22(17-24(23)31-25)29-27(33)20-9-5-2-6-10-20;30-23(14-19-3-1-11-32-19)26-17-7-5-16(6-8-17)25-28-21-10-9-18(13-22(21)29-25)27-24(31)15-20-4-2-12-33-20;30-24(17-5-1-2-6-17)26-19-11-9-16(10-12-19)23-28-21-14-13-20(15-22(21)29-23)27-25(31)18-7-3-4-8-18;1-24(2,3)14-21(30)26-17-9-7-16(8-10-17)23-28-19-12-11-18(13-20(19)29-23)27-22(31)15-25(4,5)6;30-22(18-3-1-11-24-18)26-15-7-5-14(6-8-15)21-28-17-10-9-16(13-20(17)29-21)27-23(31)19-4-2-12-25-19/h7-13,17-20H,1-6H2,(H,36,42)(H,37,43)(H,38,39);13-19,21-22H,1-12H2,(H,30,34)(H,31,35)(H,32,33);11-17,19-20H,1-10H2,(H,28,32)(H,29,33)(H,30,31);1-13H,14-15H2,(H,26,30)(H,27,31)(H,28,29);9-15,17-18H,1-8H2,(H,26,30)(H,27,31)(H,28,29);7-13H,14-15H2,1-6H3,(H,26,30)(H,27,31)(H,28,29);5-10,13,18-19,24-25H,1-4,11-12H2,(H,26,30)(H,27,31)(H,28,29)
InChIKeyFQTXXRBBPFDSAM-UHFFFAOYSA-N
MW3253.93 g/mol
LogP39.31
Rot. Bonds39

About N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide

N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide (PubChem CID 158114027) has the molecular formula C183H200F6N30O16S2 and a molecular weight of 3253.93 g/mol. Its IUPAC name is N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide.

Molecular Properties

Compound NameN-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide
PubChem CID158114027
Molecular FormulaC183H200F6N30O16S2
Molecular Weight3253.93 g/mol
Exact Mass3251.51
IUPAC NameN-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide
SMILESCC(C)(C)CC(=O)Nc1ccc(-c2nc3ccc(NC(=O)CC(C)(C)C)cc3[nH]2)cc1.O=C(Cc1cccs1)Nc1ccc(-c2nc3ccc(NC(=O)Cc4cccs4)cc3[nH]2)cc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4C(=O)C(F)(F)F)cc3[nH]2)cc1)C1CCCC1C(=O)C(F)(F)F.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCCC4)cc3[nH]2)cc1)C1CCCCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCN4)cc3[nH]2)cc1)C1CCCN1
InChIInChI=1S/C29H26F6N4O4.C29H36N4O2.C27H32N4O2.C25H20N4O2S2.C25H28N4O2.C25H32N4O2.C23H26N6O2/c30-28(31,32)23(40)17-3-1-5-19(17)26(42)36-15-9-7-14(8-10-15)25-38-21-12-11-16(13-22(21)39-25)37-27(43)20-6-2-4-18(20)24(41)29(33,34)35;34-28(21-9-5-1-2-6-10-21)30-23-15-13-20(14-16-23)27-32-25-18-17-24(19-26(25)33-27)31-29(35)22-11-7-3-4-8-12-22;32-26(19-7-3-1-4-8-19)28-21-13-11-18(12-14-21)25-30-23-16-15-22(17-24(23)31-25)29-27(33)20-9-5-2-6-10-20;30-23(14-19-3-1-11-32-19)26-17-7-5-16(6-8-17)25-28-21-10-9-18(13-22(21)29-25)27-24(31)15-20-4-2-12-33-20;30-24(17-5-1-2-6-17)26-19-11-9-16(10-12-19)23-28-21-14-13-20(15-22(21)29-23)27-25(31)18-7-3-4-8-18;1-24(2,3)14-21(30)26-17-9-7-16(8-10-17)23-28-19-12-11-18(13-20(19)29-23)27-22(31)15-25(4,5)6;30-22(18-3-1-11-24-18)26-15-7-5-14(6-8-15)21-28-17-10-9-16(13-20(17)29-21)27-23(31)19-4-2-12-25-19/h7-13,17-20H,1-6H2,(H,36,42)(H,37,43)(H,38,39);13-19,21-22H,1-12H2,(H,30,34)(H,31,35)(H,32,33);11-17,19-20H,1-10H2,(H,28,32)(H,29,33)(H,30,31);1-13H,14-15H2,(H,26,30)(H,27,31)(H,28,29);9-15,17-18H,1-8H2,(H,26,30)(H,27,31)(H,28,29);7-13H,14-15H2,1-6H3,(H,26,30)(H,27,31)(H,28,29);5-10,13,18-19,24-25H,1-4,11-12H2,(H,26,30)(H,27,31)(H,28,29)
InChIKeyFQTXXRBBPFDSAM-UHFFFAOYSA-N
XLogP39.31
TPSA666.36 Ų
H-Bond Donors23
H-Bond Acceptors27
Rotatable Bonds39
Heavy Atoms237
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003253.93
LogP ≤ 539.31
H-Bond Donors ≤ 523
H-Bond Acceptors ≤ 1027

Analyze N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide?
The IUPAC name of N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide (CID 158114027) is N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide.
What is the SMILES notation for N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide?
The canonical SMILES for N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide is CC(C)(C)CC(=O)Nc1ccc(-c2nc3ccc(NC(=O)CC(C)(C)C)cc3[nH]2)cc1.O=C(Cc1cccs1)Nc1ccc(-c2nc3ccc(NC(=O)Cc4cccs4)cc3[nH]2)cc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4C(=O)C(F)(F)F)cc3[nH]2)cc1)C1CCCC1C(=O)C(F)(F)F.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCCC4)cc3[nH]2)cc1)C1CCCCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCN4)cc3[nH]2)cc1)C1CCCN1.
What is the InChIKey of N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide?
The InChIKey is FQTXXRBBPFDSAM-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H26F6N4O4.C29H36N4O2.C27H32N4O2.C25H20N4O2S2.C25H28N4O2.C25H32N4O2.C23H26N6O2/c30-28(31,32)23(40)17-3-1-5-19(17)26(42)36-15-9-7-14(8-10-15)25-38-21-12-11-16(13-22(21)39-25)37-27(43)20-6-2-4-18(20)24(41)29(33,34)35;34-28(21-9-5-1-2-6-10-21)30-23-15-13-20(14-16-23)27-32-25-18-17-24(19-26(25)33-27)31-29(35)22-11-7-3-4-8-12-22;32-26(19-7-3-1-4-8-19)28-21-13-11-18(12-14-21)25-30-23-16-15-22(17-24(23)31-25)29-27(33)20-9-5-2-6-10-20;30-23(14-19-3-1-11-32-19)26-17-7-5-16(6-8-17)25-28-21-10-9-18(13-22(21)29-25)27-24(31)15-20-4-2-12-33-20;30-24(17-5-1-2-6-17)26-19-11-9-16(10-12-19)23-28-21-14-13-20(15-22(21)29-23)27-25(31)18-7-3-4-8-18;1-24(2,3)14-21(30)26-17-9-7-16(8-10-17)23-28-19-12-11-18(13-20(19)29-23)27-22(31)15-25(4,5)6;30-22(18-3-1-11-24-18)26-15-7-5-14(6-8-15)21-28-17-10-9-16(13-20(17)29-21)27-23(31)19-4-2-12-25-19/h7-13,17-20H,1-6H2,(H,36,42)(H,37,43)(H,38,39);13-19,21-22H,1-12H2,(H,30,34)(H,31,35)(H,32,33);11-17,19-20H,1-10H2,(H,28,32)(H,29,33)(H,30,31);1-13H,14-15H2,(H,26,30)(H,27,31)(H,28,29);9-15,17-18H,1-8H2,(H,26,30)(H,27,31)(H,28,29);7-13H,14-15H2,1-6H3,(H,26,30)(H,27,31)(H,28,29);5-10,13,18-19,24-25H,1-4,11-12H2,(H,26,30)(H,27,31)(H,28,29).
What are the key properties of N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide?
N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide has a molecular weight of 3253.93 g/mol, XLogP of 39.31, 39 rotatable bonds, 23 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[6-(cycloheptanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cycloheptanecarboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]cyclopentanecarboxamide;N-[4-[6-(3,3-dimethylbutanoylamino)-1H-benzimidazol-2-yl]phenyl]-3,3-dimethylbutanamide;N-[4-[6-(pyrrolidine-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyrrolidine-2-carboxamide;2-thiophen-2-yl-N-[4-[6-[(2-thiophen-2-ylacetyl)amino]-1H-benzimidazol-2-yl]phenyl]acetamide;2-(2,2,2-trifluoroacetyl)-N-[4-[6-[[2-(2,2,2-trifluoroacetyl)cyclopentanecarbonyl]amino]-1H-benzimidazol-2-yl]phenyl]cyclopentane-1-carboxamide is sourced from PubChem (CID 158114027), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).